menu search

Empty capsules market set to create opportunities in abundance, projected to reach us$ 4.9 billion by 2033 | future market insights, inc.

The Empty Capsules Market is vital in pharmaceuticals and nutraceuticals, offering versatile encapsulat...

September 26, 2023, 10:30 am

Intercept pharmaceuticals' stock set to soar after alfasigma buyout deal for an 82% premium

Shares of Intercept pharmaceuticals Inc. ICPT, -0.38% were set to soar Tuesday, after the bio...

September 26, 2023, 8:12 am

Astrazeneca looks to china for growth - but ceo says spinoff not happening

AstraZeneca is the largest foreign owned pharmaceutical company in China based on revenue, and they're ...

September 26, 2023, 8:00 am

Ionis pharma's genetic disorder drug meets main goal in late-stage study

Ionis pharmaceuticals said on Tuesday its experimental drug met main goal in a late-stage trial testing...

September 26, 2023, 7:13 am

Acadia pharmaceuticals: difficult market masks progress

Acadia pharmaceuticals' gains recently disappeared despite the strong launch of Daybue. Poor market con...

September 26, 2023, 6:44 am

Mgc pharmaceuticals proposes financial and capital restructuring plan

MGC pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) said directors have been forced to propose a fina...

September 26, 2023, 4:26 am

Nuvectis pharma announces updated date and time for the 2023 cantor global healthcare conference corporate presentation

Fort Lee, NJ, Sept. 25, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage bio...

September 25, 2023, 11:30 pm

Ultragenyx launches evkeeza® (evinacumab for injection) in canada for the treatment of homozygous familial hypercholesterolemia (hofh)

Evkeeza is a first-in-class medicine approved by Health Canada, the U.S. Food and Drug Administration (FDA) and European Commission (EC) to treat an u...

September 25, 2023, 9:13 pm

Nuvectis pharma announces updated date and time for the 2023 cantor global healthcare conference corporate presentation

Fort Lee, NJ, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage bio...

September 25, 2023, 7:30 pm

Astrazeneca stock upgraded to buy at jefferies

Shares of biopharmaceutical giant AstraZeneca (AZN) were upgraded to "Buy" from "Hold" at Jefferies. Th...

September 25, 2023, 4:24 pm

Pieris pharmaceuticals (pirs) upgraded to strong buy: here's why

Pieris pharmaceuticals (PIRS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing opt...

September 25, 2023, 1:32 pm

Regeneron completes acquisition of decibel therapeutics, adding promising gene therapy programs for hearing loss

TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) — Regeneron pharmaceuticals, Inc. (NASDAQ: REGN) tod...

September 25, 2023, 12:34 pm

Soleno therapeutics to present at the cantor global healthcare conference

REDWOOD CITY, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage bio...

September 25, 2023, 12:00 pm

Bullfrog ai founder and ceo vin singh to present company overview at biofuture 2023

GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a te...

September 25, 2023, 12:00 pm

Reasons to retain west pharmaceutical (wst) in your portfolio

West pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products bu...

September 25, 2023, 11:17 am

Astrazeneca upgraded on potential for non-oncology assets

AstraZeneca PLC (LSE:AZN)'s assets beyond oncology offer significant upside potential, in the view of investment bank, Jefferies. The broker upgraded ...

September 25, 2023, 9:58 am

Novo nordisk partners with valo health on ai drug discovery

Novo Nordisk NVO, +0.01% on Monday announced a partnership with Valo Health Inc., a technology company specializing in AI-powered drug discovery and d...

September 25, 2023, 8:28 am

Are gene therapy stocks the market's next big winners?

It's not often that you see a company whose main product comes with a price tag of over $2 million, but that's the case with biotechs BioMarin ...

September 25, 2023, 8:06 am

Should you invest in the invesco pharmaceuticals etf (pjp)?

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco pharma...

September 25, 2023, 7:31 am

Cybin to participate in the cantor global healthcare conference

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage bio...

September 25, 2023, 7:30 am


Search within

Pages Search Results: